Science & technology | Monoclonal antibodies

Silver-bullet jubilee

|

FOR all the buzz that surrounds biotechnology, you might imagine it was a brand new science. In fact, it is old: so old, indeed, that one of the cornerstones of modern biotech, the monoclonal antibody, celebrated its 25th birthday on August 7th. When César Milstein and Georges Köhler, two researchers at the Laboratory of Molecular Biology in Cambridge, England, first published a way to produce highly specific antibodies in a test tube, they speculated that it might have some commercial value. But as Dr Milstein points out, they never imagined their invention would grow into a multi-billion dollar market used to diagnose and, more recently to treat, disease.

This article appeared in the Science & technology section of the print edition under the headline “Silver-bullet jubilee”

Will the real Al Gore please stand up

From the August 12th 2000 edition

Discover stories from this section and more in the list of contents

Explore the edition

Discover more

Dr Dorothy Bishop.

Elon Musk is causing problems for the Royal Society

His continued membership has led to a high-profile resignation

Legal Amazon preservation area borders the field for soybean planting.

Deforestation is costing Brazilian farmers millions

Without trees to circulate moisture, the land is getting hotter and drier


Robot mixing at Toyota Research Institute.

Robots can learn new actions faster thanks to AI techniques

They could soon show their moves in settings from car factories to care homes


Scientists are learning why ultra-processed foods are bad for you

A mystery is finally being solved

Scientific publishers are producing more papers than ever

Concerns about some of their business models are building

The two types of human laugh

One is caused by tickling; the other by everything else